A PHASE IV MULTICENTER, OPEN-LABEL STUDY EVALUATING B CELL LEVELS IN INFANTS POTENTIALLY EXPOSED TO OCRELIZUMAB DURING PREGNANCY - THE MINORE STUDY
Details
Age
Child to Adult
Type of Study
Outcomes Research
Locations
Outpatient CTRC
University of Colorado Hospital
Principal Investigator
Anna Shah, MD
Study ID
Protocol Number: 22-0386
More information available at ClinicalTrials.gov: NCT04998812
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers